Loading...
OTCM
INLB
Market cap0kUSD
Apr 09, Last price  
0.00USD
Name

Item 9 Labs Corp

Chart & Performance

D1W1MN
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
33.02%
Revenues
22m
-0.82%
0892,187341,991179,494113,022324,026243,9261,375,2954,933,9608,121,73321,937,22721,756,997
Net income
-31m
L+92.56%
-23,112-4,087,714-3,325,069-17,082,226-4,740,684-3,125,536-266,571-642,282-10,631,157-12,299,657-16,191,961-31,179,053
CFO
-2m
L-62.36%
-14,922-966,175-353,544-738,598-740,849-339,72468,906-975,762-2,393,428-1,141,416-5,989,581-2,254,362

Profile

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
IPO date
Nov 03, 2011
Employees
97
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑09
Income
Revenues
21,757
-0.82%
Cost of revenue
33,275
Unusual Expense (Income)
NOPBT
(11,518)
NOPBT Margin
Operating Taxes
13
Tax Rate
NOPAT
(11,532)
Net income
(31,179)
92.56%
Dividends
Dividend yield
Proceeds from repurchase of equity
658
BB yield
-1.74%
Debt
Debt current
19,946
Long-term debt
8,854
Deferred revenue
336
Other long-term liabilities
(7,217)
Net debt
20,996
Cash flow
Cash from operating activities
(2,254)
CAPEX
(5,458)
Cash from investing activities
(5,160)
Cash from financing activities
6,046
FCF
(4,746)
Balance
Cash
86
Long term investments
7,718
Excess cash
6,716
Stockholders' equity
(65,027)
Invested Capital
145,832
ROIC
ROCE
EV
Common stock shares outstanding
95,691
Price
0.40
-75.16%
Market cap
37,798
-69.75%
EV
58,773
EBITDA
(9,596)
EV/EBITDA
Interest
6,415
Interest/NOPBT